Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
309 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
Evans talks about DNA analysis on HuffPost Live
by maryruth.helms published Sep 25, 2012 last modified Sep 25, 2012 10:57 AM — filed under: , ,
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, provided his perspective on a HuffPost Live broadcast that aired on September 24, 2012.
Located in News / 2012 News
UNC Lineberger scientists lead cancer genome analysis of breast cancer
by maryruth.helms published Sep 24, 2012 last modified Oct 05, 2012 11:28 AM — filed under: , ,
Team identifies genetic causes and similarity to ovarian cancer
Located in News / 2012 News
Carey named Division Chief of Hematology-Oncology and Physician-in-Chief of the N.C. Cancer Hospital
by maryruth.helms published Sep 20, 2012 last modified Sep 25, 2012 07:57 AM — filed under: ,
Chapel Hill - Lisa A. Carey, MD, has been appointed Chief of the Division of Hematology and Oncology at the University of North Carolina School of Medicine and Physician-in-Chief of the N.C. Cancer Hospital.
Located in News / 2012 News
Informatics approach helps doctors, patients make sense of genome data
by maryruth.helms published Sep 20, 2012 last modified Sep 20, 2012 11:14 AM — filed under: , ,
Chapel Hill, NC – The cost of sequencing the entire human genome, or exome – the regions of the genome that are translated into proteins that affect cell behavior – has decreased significantly, to the point where the cost of looking at the majority of a patient’s genomic data may be less expensive than undertaking one or two targeted genetic tests.
Located in News / 2012 News
Diseases of aging map to a few ‘hotspots’ on the human genome
by maryruth.helms published Sep 19, 2012 last modified Sep 20, 2012 11:23 AM — filed under: ,
Chapel Hill, NC –Researchers have long known that individual diseases are associated with genes in specific locations of the genome.
Located in News / 2012 News
Genetically-engineered preclinical models predict pharmacodynamic response
by maryruth.helms published Sep 19, 2012 last modified Sep 27, 2012 02:09 PM — filed under: ,
Preclinical testing a necessary step in drug development
Located in News / 2012 News
NPR series focuses on gene sequencing, Evans comments
by maryruth.helms published Sep 19, 2012 last modified Sep 19, 2012 09:33 AM — filed under: , ,
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in NPR's second story in its "$1,000 Genome" series, which aired today.
Located in News / 2012 News
UNC Lineberger faculty co-author review article on adjuvant chemotherapy in women 70 years of age and older
by maryruth.helms published Sep 18, 2012 last modified Sep 19, 2012 11:47 AM — filed under: , ,
Located in News / 2012 News
Tate appointed to term on Psychosocial Risk and Disease Prevention Study Section
by maryruth.helms published Sep 17, 2012 last modified Sep 17, 2012 04:02 PM — filed under: ,
Located in News / 2012 News
Cell death mystery yields new suspect for cancer drug development
by maryruth.helms published Sep 13, 2012 last modified Sep 18, 2012 02:55 PM — filed under: ,
Chapel Hill, NC – A mysterious form of cell death, coded in proteins and enzymes, led to a discovery by UNC researchers uncovering a prime suspect for new cancer drug development.
Located in News / 2012 News